MI-Luciferase-IRES-mCherry Citations (8)

Originally described in: Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1epsilon.
Mallampati S, Sun B, Lu Y, Ma H, Gong Y, Wang D, Lee JS, Lin K, Sun X Blood. 2014 Jun 26;123(26):4064-76. doi: 10.1182/blood-2013-12-543801. Epub 2014 Apr 30. PubMed Journal

---

Articles Citing MI-Luciferase-IRES-mCherry

Articles
Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer. Vasudevan A, Baruah PS, Smith JC, Wang Z, Sayles NM, Andrews P, Kendall J, Leu J, Chunduri NK, Levy D, Wigler M, Storchova Z, Sheltzer JM. Dev Cell. 2020 Feb 24;52(4):413-428.e6. doi: 10.1016/j.devcel.2020.01.034. PubMed
In vivo imaging of retrovirus infection reveals a role for Siglec-1/CD169 in multiple routes of transmission. Haugh KA, Ladinsky MS, Ullah I, Stone HM, Pi R, Gilardet A, Grunst MW, Kumar P, Bjorkman PJ, Mothes W, Uchil PD. Elife. 2021 Jul 5;10. pii: 64179. doi: 10.7554/eLife.64179. PubMed
TIAM1-RAC1 promote small-cell lung cancer cell survival through antagonizing Nur77-induced BCL2 conformational change. Payapilly A, Guilbert R, Descamps T, White G, Magee P, Zhou C, Kerr A, Simpson KL, Blackhall F, Dive C, Malliri A. Cell Rep. 2021 Nov 9;37(6):109979. doi: 10.1016/j.celrep.2021.109979. PubMed
Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR. Zhang AQ, Hostetler A, Chen LE, Mukkamala V, Abraham W, Padilla LT, Wolff AN, Maiorino L, Backlund CM, Aung A, Melo M, Li N, Wu S, Irvine DJ. Nat Biomed Eng. 2023 Sep;7(9):1113-1128. doi: 10.1038/s41551-023-01048-8. Epub 2023 Jun 8. PubMed
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment. Yabushita T, Chinen T, Nishiyama A, Asada S, Shimura R, Isobe T, Yamamoto K, Sato N, Enomoto Y, Tanaka Y, Fukuyama T, Satoh H, Kato K, Saitoh K, Ishikawa T, Soga T, Nannya Y, Fukagawa T, Nakanishi M, Kitagawa D, Kitamura T, Goyama S. Cell Rep. 2023 Sep 26;42(9):113098. doi: 10.1016/j.celrep.2023.113098. Epub 2023 Sep 14. PubMed
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy. Marone R, Landmann E, Devaux A, Lepore R, Seyres D, Zuin J, Burgold T, Engdahl C, Capoferri G, Dell'Aglio A, Larrue C, Simonetta F, Rositzka J, Rhiel M, Andrieux G, Gallagher DN, Schroder MS, Wiederkehr A, Sinopoli A, Do Sacramento V, Haydn A, Garcia-Prat L, Divsalar C, Camus A, Xu L, Bordoli L, Schwede T, Porteus M, Tamburini J, Corn JE, Cathomen T, Cornu TI, Urlinger S, Jeker LT. J Exp Med. 2023 Dec 4;220(12):e20231235. doi: 10.1084/jem.20231235. Epub 2023 Sep 29. PubMed
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis. Gammelgaard OL, Terp MG, Kirkin AF, Johansen S, Traynor S, Vever H, Guldberg P, Kodahl AR, Gjerstorff MF, Ditzel HJ. Mol Cancer. 2024 Jan 6;23(1):6. doi: 10.1186/s12943-023-01914-8. PubMed
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor. Mei W, Faraj Tabrizi S, Godina C, Lovisa AF, Isaksson K, Jernstrom H, Tavazoie SF. Cell. 2025 Jan 23;188(2):371-389.e28. doi: 10.1016/j.cell.2024.11.009. Epub 2024 Dec 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.